Press releases
16 December 2020
|
16:35 PM CET
First patient enrolment in MIMICS 3D USA
Veryan Medical (Horsham, UK) is delighted to announce that the first patient was enrolled today in the MIMICS-3D USA study by John H. Rundback MD at NJ Endovascular & Amputation Prevention, NJ.
02 September 2020
|
19:01 PM CEST
First BioMimics 3D US Implant
Veryan Medical (Horsham, UK) has announced that Dr. Bret Wiechmann and his team at Vascular and Interventional Physicians in Gainesville, FL implanted the first commercial BioMimics 3D Vascular stent in the US, on the same day that the device was officially launched in the US. The BioMimics 3D self-expanding, nitinol stent features a highly differentiated, helical centre-line design that has achieved excellent clinical outcomes in clinical trials, including a pivotal study with 3-year follow-up, MIMICS-2.
01 September 2020
|
10:21 AM CEST
BioMimics 3D US launch
Veryan Medical (Horsham, UK) today announced that it has launched the innovative BioMimics 3D Vascular Stent System in the US. The BioMimics 3D self-expanding, nitinol stent features a highly-differentiated, helical centre-line design that has achieved excellent clinical outcomes in clinical trials, including a pivotal study with 3-year follow-up.
08 July 2020
|
15:54 PM CEST
Joint press release- Veryan & Walk Vascular -8th July 2020
Walk Vascular, LLC (Irvine, CA) and Veryan Medical (Horsham, UK) have announced that from today Veryan Medical will support Walk Vascular in the commercialization of the innovative JETi Peripheral Thrombectomy System in Germany.
09 June 2020
|
10:45 AM CEST
MIMICS-2 3-year data update
Professor Thomas Zeller (University Heart Centre Freiburg, Bad Krozingen, Germany) today presented the 36-month results from Veryan Medical’s MIMICS-2 study at CX 2020 Live.
13 December 2018
|
01:00 AM CET
01 June 2018
|
02:00 AM CEST
June 2018
Veryan Medical press release on completion of MIMICS 3D enrollment. 20th June 2018
01 February 2018
|
01:00 AM CET
01 January 2018
|
01:00 AM CET
01 September 2017
|
02:00 AM CEST
September 2017
Professor Thomas Zeller MD announces new significant outcomes from the Mimics Study